Global Biological Buffers Market

Global Biological Buffers Market, By Buffers Type (Goods Buffers, Other Salt-Based Buffers), Formulation (Powder, Liquid), Application (Pharmaceutical & Biopharmaceuticals, Cell Culture & Molecular Biology, Clinical & Diagnostic Applications, Chemical & Industrial Applications, Others), End User (Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Research & Academic Institutes, Diagnostic Laboratories, Contract Research Organizations (CROs) & CMOs), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Russia, Netherlands, Switzerland, Turkey, Austria, Poland, Ireland, Norway, Rest of Europe, Japan, China, South Korea, India, Singapore, Thailand, Indonesia, Malaysia, Philippines, Australia, New Zealand, Taiwan, Rest of Asia-Pacific, Brazil, Argentina, Chile, Peru, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Kuwait, Israel, Rest Of Middle East And Africa) - Industry Trends and Forecast to 2035

Market Definition

Biological buffers are solutions containing a weak acid and its conjugate base (or a weak base and its conjugate acid) that resist changes in pH upon the addition of an acid or base. They are crucial in biological systems and laboratory settings to maintain a stable pH environment, as enzymes and other biomolecules are highly sensitive to pH fluctuations. Common biological buffers include phosphate, Tris, and HEPES, each with a specific buffering range suitable for different applications.

Market Segmentation

Global biological buffers market is categorized into four notable segments based on buffer type, formulation, application, and end user
• On the basis of buffer type, the market is segmented into Goods Buffers, Other Salt-Based Buffers
• On the basis of formulation, the market is segmented into Powder, Liquid
• On the basis of application, the market is segmented into Pharmaceutical & Biopharmaceuticals, Cell Culture & Molecular Biology, Clinical & Diagnostic Applications, Chemical & Industrial Applications, Others
• On the basis of end user, the market is segmented into Pharmaceutical & Biopharmaceutical Companies, Biotechnology Companies, Research & Academic Institutes, Diagnostic Laboratories, Contract Research Organizations (CROs) & CMOs

Market Players

The key players operating in the global biological buffers market are:
• F. Hoffmann-La Roche Ltd
• Bio-Rad Laboratories, Inc.
• Thermo Fisher Scientific Inc.
• Takara Bio Inc.
• Merck KGaA
• Avantor, Inc.
• Advancion Corporation
• Santa Cruz Biotechnology Inc.
• MP Biomedicals.
• Promega Corporation
• Beckman Coulter, Inc.
• QIAGEN
• HiMedia Laboratories
• Cayman Chemical
• Biosynth
• SERVA Electrophoresis GmbH
• FUJIFILM Wako Pure Chemical Corporation
• Reagecon Diagnostics Ltd
• GoldBio
• nacalai.com.
• HOPAX

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver. Show more